revealed that while transient skin-benefitting results were seen in 37.5% of patients with IV glutathione (1200 mg twice weekly for six weeks), 32% developed adverse events, again revealing a large risk-to-benefit ratio imbalance
What we see is that the efficacy, safety, and tolerability are really consistent with the very best injectable GLP-1s, says Kenneth Custer, president of cariometabolic health at Eli Lilly, of the companys experimental pill
Thunder Power makes some of the nicest (and most expensive) LiPo packs in the industry, but their connector is not compatible with 95% of the chargers on the market, at least out of the box (most chargers will require an adapter from the more common JST-XH to the TP connector)
No side effects doesn't mean the medication isn't working
Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction